To investigate the specific mechanisms by which ZDHHC20 regulates pancreatic cancer progression, we conducted immunoprecipitation–tandem mass spectrometry (IP-MS) to identify potential binding partners of ZDHHC20. The gene discussed is ZDHHC20; the disease is pancreatic neoplasm.